Abstract:
:In the development of a new treatment in oncology, phase II trials play a key role. On the basis of the data obtained during phase II, it is decided whether the treatment should be studied further. Therefore, the decision to be made on the basis of the data of a phase II trial must be as accurate as possible. For ethical and economic reasons, phase II trials are usually performed with a planned interim analysis. Furthermore, the decision about stopping or continuing the study is usually based on a short-term outcome like tumor response, whereas secondary endpoints comprise stable disease, progressive disease, toxicity, and/or overall survival. The data obtained in a phase II trial are often analyzed and interpreted by applying the maximum likelihood estimator (MLE) without taking into account the sequential nature of the trial. However, this approach provides biased results and may therefore lead to wrong conclusions. Whereas unbiased estimators for two-stage designs have been derived for the primary endpoint, such estimators are currently not available for secondary endpoints. We present uniformly minimum variance unbiased estimators (UMVUE) for secondary endpoints in two-stage designs that allow stopping for futility (and efficacy). We compare the mean squared error of the UMVUE and the MLE and investigate the efficiency of the UMVUE. A clinical trial example illustrates the application.
journal_name
Stat Medjournal_title
Statistics in medicineauthors
Kunz CU,Kieser Mdoi
10.1002/sim.5585subject
Has Abstractpub_date
2012-12-30 00:00:00pages
4352-68issue
30eissn
0277-6715issn
1097-0258journal_volume
31pub_type
杂志文章abstract::In cancer clinical trials, patients often experience a recurrence of disease prior to the outcome of interest, overall survival. Additionally, for many cancers, there is a cured fraction of the population who will never experience a recurrence. There is often interest in how different covariates affect the probability...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6056
更新日期:2014-05-10 00:00:00
abstract::In this commentary, we revisit Sir Austin Bradford Hill's seminal Alfred Watson Memorial Lecture in 1962 through the eyes of two practicing biostatisticians of the current era. We summarize some eternal takeaway messages from Hill's lecture regarding observations and experiments translated through the modern lexicon o...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8830
更新日期:2021-01-15 00:00:00
abstract::Novel methodology is implemented to assess the predictive power of covariate information associated with sequential binary events. Logistic models are first fitted on the basis of a subset of the observations and then evaluated sequentially on the rest. The probabilistic forecasts are compared to the outcomes via a sc...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(SICI)1097-0258(19961030)15:20<2149::AID-S
更新日期:1996-10-30 00:00:00
abstract::The relationship between association and surrogacy has been the focus of much debate in the surrogate marker literature. Recently, the individual causal association (ICA) has been introduced as a metric of surrogacy in the causal inference framework, when both the surrogate and the true endpoint are normally distribut...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8698
更新日期:2020-11-20 00:00:00
abstract::In this paper, we proposed a mechanistic breast cancer survival model based on the axillary lymph node chain structure, considering lymph nodes as a potential dissemination arrangement. We assume a naive breast cancer treatment protocol consisting of exposing patients first to a chemotherapy treatment on r intervals a...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5576
更新日期:2013-04-30 00:00:00
abstract::The FDA Guidance, while highly appropriate for industry sponsored trials, need not be imposed on publicly (e.g. NIH) financed clinical trials. While the potential for conflicts of interest exist in the latter, they are in general manageable and pose an acceptable low risk of threatening the integrity of a study. Howev...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1787
更新日期:2004-05-30 00:00:00
abstract::In this paper we study the problem of variable selection for the proportional odds model, which is a useful alternative to the proportional hazards model and might be appropriate when the proportional hazards assumption is not satisfied. We propose to fit the proportional odds model by maximizing the marginal likeliho...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2833
更新日期:2007-09-10 00:00:00
abstract::The serial dilution assay (for example, an in vitro antimicrobic susceptibility test or a serum antibody titer assay) is an important technique in biomedical research. The structure of the experiment forces grouping of the threshold concentrations into intervals. Statistical methods to analyse threshold concentrations...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780070410
更新日期:1988-04-01 00:00:00
abstract::Although all clinical trials are designed and monitored using more than one endpoint, methods are needed to assure that decision criteria are chosen to reflect the clinically relevant tradeoffs that assure the trial's scientific integrity. This article presents a framework for the design and monitoring clinical trials...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8696
更新日期:2020-11-20 00:00:00
abstract::A study of long term survival of 1487 patients given an allogeneic bone marrow transplant for acute myelogenous leukaemia and 729 patients given a transplant for severe aplastic anaemia was conducted by the International Bone Marrow Transplant Registry. One aim of this study is to determine if the mortality rates of t...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19990630)18:12<1529::aid-s
更新日期:1999-06-30 00:00:00
abstract::Many extensions of survival models based on the Cox proportional hazards approach have been proposed to handle clustered or multiple event data. Of particular note are five Cox-based models for recurrent event data: Andersen and Gill (AG); Wei, Lin and Weissfeld (WLW); Prentice, Williams and Peterson, total time (PWP-...
journal_title:Statistics in medicine
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1002/(sici)1097-0258(20000115)19:1<13::aid-sim2
更新日期:2000-01-15 00:00:00
abstract::A review is given of different ways of estimating the error rate of a prediction rule based on a statistical model. A distinction is drawn between apparent, optimum and actual error rates. Moreover it is shown how cross-validation can be used to obtain an adjusted predictor with smaller error rate. A detailed discussi...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780091109
更新日期:1990-11-01 00:00:00
abstract::In a recent Statistics in Medicine paper, Warn, Thompson and Spiegelhalter (WTS) made a comparison between the Bayesian approach to the meta-analysis of binary outcomes and a popular Classical approach that uses summary (two-stage) techniques. They included approximate summary (two-stage) Bayesian techniques in their ...
journal_title:Statistics in medicine
pub_type: 评论,信件
doi:10.1002/sim.2115
更新日期:2005-09-15 00:00:00
abstract::Most longitudinal growth curve models evaluate the evolution of each of the anthropometric measurements separately. When applied to a 'reference population', this exercise leads to univariate reference curves against which new individuals can be evaluated. However, growth should be evaluated in totality, that is, by e...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6411
更新日期:2015-04-15 00:00:00
abstract::Conventional seamless phase 2/3 design with fixed sample size determination (SSD) has gained its popularity in oncology drug development due to attractive features such as significantly shortening the development timeline, minimizing sample size, as well as early decision making. However, this design is not immune to ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8543
更新日期:2020-08-15 00:00:00
abstract::The purpose of this research was to develop appropriate methods for analysing repeated ordinal categorical data that arose in an intervention trial to prevent oesophageal cancer. The measured response was the degree of oesophageal dysplasia at 2.5 and 6 years after randomization. An important feature was that some res...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780130511
更新日期:1994-03-15 00:00:00
abstract::We examine Goodman and Kruskal's lambda using Efron's approach to regression and analysis of variance (ANOVA) for zero-one outcome data. For a binary response cross-classified by a single nominal predictor, we present a computationally simple ANOVA table in which lambda is analogous to Pearson's R-square. We character...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780080511
更新日期:1989-05-01 00:00:00
abstract::The one-step (Peto) method for obtaining pooled effect estimates can yield extremely biased results when applied to unbalanced data. Even for balanced studies, the one-step estimate may incorporate an unacceptable degree of bias. In place of the one-step estimate, we recommend use of ordinary Mantel-Haenszel, weighted...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780090307
更新日期:1990-03-01 00:00:00
abstract::A problem occurring in chronic disease modeling is the estimation of transition probabilities of moving from one state of a categorical risk factor to another. Transitions could be obtained from a cohort study, but often such data may not be available. However, under the assumption that transitions remain stable over ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4423
更新日期:2012-03-15 00:00:00
abstract::With the increasing availability of detailed clinical information, there is optimism that treatment choices can be selectively directed to those individuals most likely to benefit. While standard clinical trials can establish whether a treatment appears to be effective on average, subsequent work is needed to determin...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6138
更新日期:2014-07-30 00:00:00
abstract::Group sequential hypothesis testing is now widely used to analyze prospective data. If Monte Carlo simulation is used to construct the signaling threshold, the challenge is how to manage the type I error probability for each one of the multiple tests without losing control on the overall significance level. This paper...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6805
更新日期:2016-04-30 00:00:00
abstract::In clinical research, investigators are interested in inferring the average causal effect of a treatment. However, the causal parameter that can be used to derive the average causal effect is not well defined for ordinal outcomes. Although some definitions have been proposed, they are limited in that they are not iden...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7400
更新日期:2017-11-10 00:00:00
abstract::The asymptotic Pearson's chi-squared test and Fisher's exact test have long been the most used for testing association in 2x2 tables. Unconditional tests preserve the significance level and generally are more powerful than Fisher's exact test for moderate to small samples, but previously were disadvantaged by being co...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3531
更新日期:2009-03-30 00:00:00
abstract::In clinical research, we are often interested in assessing how a biomarker changes with time, and whether it could be used as a surrogate marker when evaluating the efficacy of a new drug. However, when the longitudinal marker is correlated with survival, linear mixed models for longitudinal data may be inappropriate....
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3142
更新日期:2007-12-30 00:00:00
abstract::The U.S. Food and Drug Administration (FDA) has proposed new regulations that address the 'prescribability' and 'switchability' of new formulations of already-approved drugs. These new criteria are known, respectively, as population and individual bioequivalence. Two methods have been proposed in the bioequivalence li...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1346
更新日期:2003-01-15 00:00:00
abstract::Observational cohort studies often feature longitudinal data subject to irregular observation. Moreover, the timings of observations may be associated with the underlying disease process and must thus be accounted for when analysing the data. This paper suggests that multiple outputation, which consists of repeatedly ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6829
更新日期:2016-05-20 00:00:00
abstract::This paper presents tables analogous to T-tables for use in the 2 x 2 multinomial trial, where the continuity corrected Z-statistic is used to make exact unconditional inference. This is the first solution of a discrete exact unconditional inference problem involving a multivariate nuisance parameter for which no anci...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780110708
更新日期:1992-05-01 00:00:00
abstract::A preference trial is a special form of cross-over trial where clinical conditions determine when patients change treatment, in a prescribed order. This can be modelled using a geometric distribution. The model can be simply fitted using standard logistic regression methodology. The procedure is applied to a trial stu...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(SICI)1097-0258(19960229)15:4<443::AID-SIM
更新日期:1996-02-28 00:00:00
abstract::Multilevel mixed effects survival models are used in the analysis of clustered survival data, such as repeated events, multicenter clinical trials, and individual participant data (IPD) meta-analyses, to investigate heterogeneity in baseline risk and covariate effects. In this paper, we extend parametric frailty model...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6191
更新日期:2014-09-28 00:00:00
abstract::While genome-wide association studies (GWASs) have been widely used to uncover associations between diseases and genetic variants, standard SNP-level GWASs often lack the power to identify SNPs that individually have a moderate effect size but jointly contribute to the disease. To overcome this problem, pathway-based ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8442
更新日期:2020-03-15 00:00:00